News Image

QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs

Provided By PR Newswire

Last update: Jul 7, 2025

New executives bring deep expertise to elevate quality and accelerate innovation across global operations

SAN DIEGO, July 7, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has appointed two industry-leading executives to its leadership team. Devon Burek joins the Company as Senior Vice President of Global Quality, and Sergio Gadaleta joins as Senior Vice President of Clinical and Regulatory Affairs. These hires reflect the Company's continued investment in operational excellence, product quality and regulatory innovation to support global growth.

Read more at prnewswire.com

QUIDELORTHO CORP

NASDAQ:QDEL (8/26/2025, 8:00:01 PM)

After market: 27.85 -0.07 (-0.25%)

27.92

+0.27 (+0.98%)



Find more stocks in the Stock Screener

Follow ChartMill for more